Anzeige
Mehr »
Mittwoch, 15.07.2026 - Börsentäglich über 12.000 News
Time to Buy! Diese drei Kräfte treiben die Tiefsee-Exploration massiv an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.07.Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
08.07.Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
08.07.Catalent sells UK facility to Codis, expands Nanoscope partnership
07.07.FDA approves Vera's dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
07.07.Novartis dismisses 322 more staffers based out of US headquarters
07.07.Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
07.07.On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
07.07.Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
07.07.Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
07.07.Skin quality driving widespread quality-of-life issues: survey
06.07.FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2
06.07.Amgen issues recall for close to 1M heart med bottles due to contamination
01.07.Lonza expands partnership with US drugmaker, boosts capacity for ADCs
01.07.Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
01.07.Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
01.07.BridgeBio attracts $1B in equity for new launches, but analyst smells M&A 'dry powder'
01.07.Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
01.07.Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
01.07.Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
01.07.Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
30.06.AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
30.06.Rising Stars: How Novo Nordisk's Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
30.06.Medical journal retracts Tavneos pivotal study article, complicating Amgen's defense effort
30.06.After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
30.06.FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program